33 related articles for article (PubMed ID: 28865276)
1. Design, synthesis, and mechanism of action of 2-(3-hydroxy-5-methoxyphenyl)-6-pyrrolidinylquinolin-4-one as a potent anticancer lead.
Cheng YY; Liu CY; Tsai MT; Lin HY; Yang JS; Wu TS; Kuo SC; Huang LJ; Lee KH
Bioorg Med Chem Lett; 2013 Sep; 23(18):5223-7. PubMed ID: 23916255
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of guaianolide-germacranolide heterodimers as novel anticancer agents against hepatocellular carcinoma.
Yan JX; Li QH; Li TZ; Huang ZY; Ma YB; Chen JJ
Drug Dev Res; 2023 Sep; 84(6):1285-1298. PubMed ID: 37345274
[TBL] [Abstract][Full Text] [Related]
3. Structural re-positioning, in silico molecular modelling, oxidative degradation, and biological screening of linagliptin as adenosine 3 receptor (ADORA3) modulators targeting hepatocellular carcinoma.
Ayoub BM; Attia YM; Ahmed MS
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):858-866. PubMed ID: 29768061
[TBL] [Abstract][Full Text] [Related]
4. Novel substituted aminothiazoles as potent and selective anti-hepatocellular carcinoma agents.
Lu H; Rogowskyj J; Yu W; Venkatesh A; Khan N; Nakagawa S; Goossens N; Koh AP; Higashi T; Gunasekaran G; Schwarz ME; Hiotis SP; Xu X; Kinney W; Hoshida Y; Block T; Cuconati A; Du Y
Bioorg Med Chem Lett; 2016 Dec; 26(23):5819-5824. PubMed ID: 27793566
[TBL] [Abstract][Full Text] [Related]
5. Lipidic synthetic alkaloids as SK3 channel modulators. Synthesis and biological evaluation of 2-substituted tetrahydropyridine derivatives with potential anti-metastatic activity.
Kouba S; Braire J; Félix R; Chantôme A; Jaffrès PA; Lebreton J; Dubreuil D; Pipelier M; Zhang X; Trebak M; Vandier C; Mathé-Allainmat M; Potier-Cartereau M
Eur J Med Chem; 2020 Jan; 186():111854. PubMed ID: 31753515
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antihepatoma activity of guaianolide dimers derived from lavandiolide I.
Wang X; Li TZ; Ma YB; Ma WJ; Xue D; Chen JJ
Bioorg Med Chem Lett; 2024 May; 104():129708. PubMed ID: 38521176
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the bioactivity of novel spiroisoxazoline typecompounds against normal and cancer cell lines.
Najim N; Bathich Y; Zain MM; Hamzah AS; Shaameri Z
Molecules; 2010 Dec; 15(12):9340-53. PubMed ID: 21169884
[TBL] [Abstract][Full Text] [Related]
8. Structural Insights into N-heterocyclic Moieties as an Anticancer Agent against Hepatocellular Carcinoma: An Exhaustive Perspective.
Chourasiya NK; Fatima F; Mishra M; Kori S; Das R; Kashaw V; Iyer AK; Kashaw SK
Mini Rev Med Chem; 2023; 23(19):1871-1892. PubMed ID: 37157201
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Efficacy of OSU-2S in the Treatment of Non-Small-Cell Lung Cancer and Screening of Potential Targets of Action.
Han M; Liu X; Hailati S; Nurahmat N; Dilimulati D; Baishan A; Aikebaier A; Zhou W
Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794152
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Both Extrinsic and Intrinsic Apoptotic Pathways in Tridecylpyrrolidine-Diol Derivative-Induced Apoptosis In Vitro.
Nosalova N; Keselakova A; Kello M; Martinkova M; Fabianova D; Pilatova MB
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511455
[TBL] [Abstract][Full Text] [Related]
11. A Novel Benzopyrane Derivative Targeting Cancer Cell Metabolic and Survival Pathways.
Zaher DM; Ramadan WS; El-Awady R; Omar HA; Hersi F; Srinivasulu V; Hachim IY; Al-Marzooq FI; Vazhappilly CG; Merali S; Merali C; Soares NC; Schilf P; Ibrahim SM; Al-Tel TH
Cancers (Basel); 2021 Jun; 13(11):. PubMed ID: 34200264
[TBL] [Abstract][Full Text] [Related]
12. Antrodia cinnamomea boosts the anti-tumor activity of sorafenib in xenograft models of human hepatocellular carcinoma.
Wu WD; Chen PS; Omar HA; Arafa EA; Pan HW; Jeng J; Hung JH
Sci Rep; 2018 Aug; 8(1):12914. PubMed ID: 30150684
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of new pyrrolidine carboxamide analogues as potential chemotherapeutic agents for hepatocellular carcinoma.
Omar HA; Zaher DM; Srinivasulu V; Hersi F; Tarazi H; Al-Tel TH
Eur J Med Chem; 2017 Oct; 139():804-814. PubMed ID: 28865276
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells.
Sbenati RM; Zaraei SO; El-Gamal MI; Anbar HS; Tarazi H; Zoghbor MM; Mohamood NA; Khakpour MM; Zaher DM; Omar HA; Alach NN; Shehata MK; El-Gamal R
Eur J Med Chem; 2021 Jan; 210():113081. PubMed ID: 33310290
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel 1,3,4-trisubstituted pyrazole derivatives as potential chemotherapeutic agents for hepatocellular carcinoma.
Harras MF; Sabour R
Bioorg Chem; 2018 Aug; 78():149-157. PubMed ID: 29567429
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, molecular modelling, and biological evaluation of novel substituted pyrimidine derivatives as potential anticancer agents for hepatocellular carcinoma.
Ahmed NM; Youns M; Soltan MK; Said AM
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1110-1120. PubMed ID: 31117890
[TBL] [Abstract][Full Text] [Related]
17. Structure activity relationship (SAR) and anticancer activity of pyrrolidine derivatives: Recent developments and future prospects (A review).
Bhat AA; Singh I; Tandon N; Tandon R
Eur J Med Chem; 2023 Jan; 246():114954. PubMed ID: 36481599
[TBL] [Abstract][Full Text] [Related]
18. Anticancer Perspectives on the Fungal-Derived Polyphenolic Hispolon.
Islam MT; Ali ES; Khan IN; Shaw S; Uddin SJ; Rouf R; Dev S; Saravi SSS; Das N; Tripathi S; Yele SU; Das AK; Shilpi JA; Mishra SK; Mubarak MS
Anticancer Agents Med Chem; 2020; 20(14):1636-1647. PubMed ID: 32560616
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
